Breast cancer gene BRCA-1 cannot be patented, High Court rules
Updated 8 minutes ago
The High Court has ruled the breast cancer gene BRCA-1 cannot be patented.
Two-time cancer survivor Yvonne D'Arcy has led the legal battle over the ownership of the patent by US company Myriad Genetics.
At the heart of the case was the concern that ownership of the gene patent could stifle the research and development of treatments for genetic diseases.
Myriad Genetics argued patents ensured innovation could be commercialised for everyone's benefit.
Before the Australian case, the United States Supreme Court ruled genes were not patentable inventions but were instead inventions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.